Greystone Associates Analyzes Technical, Economic and Usability Factors Fueling the Proliferation of Innovative Syringes and Injectors

Greystone Associates Analyzes the Impact on Economic, User Preference and Therapeutic Factors on Device Growth

Greystone Associates Business and Technology Factors Fueling the Trend to Combination Devices

Greystone Associates Assessment Identifies a Number of Therapy Areas Where Pens are Achieving Double-Digit Growth

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs, and healthcare administration initiatives.

Applied Data Research Analyzes Therapeutic, Economic and Compliance Factors Driving Growth

Greystone Associates Finds Cost, Compliance Factors Influencing Dosing and Device Strategies

Greystone Associates Examines Key Technology and Commercialization Factors

User Acceptance and Compliance Linked to Dosing-Specific Packaging

Greystone Associates Assesses Key Enablers and Success Factors for Pen Injectors and Auto-Injectors

Applied Data Research Study Finds Therapy-Specific Devices and Patient-Centered Design Focus Creating New Opportunities

Greystone Associates Analyzes the Rapid Growth of Biological Combination Products